2024
Greene, S.J., Böhm, M., Bozkurt, B., Butler, J., Cleland, J.G.F., Coats, A.J.S., Desai, N.R., Grobbee, D.E., Kelepouris, E.,
Pinto, F., Rosano, G., Morin, I., Szecsödy, P., Fabien, S., Waechter, S., Crespo-Leiro, M.G., Hülsmann, M., Kempf, T., Pfister, O.,
Pouleur, A.-C., Sauer, A.J., Saxena, M., Schulz, M., Volterrani, M., Anker, S.D. and Kosiborod, M.N.:
Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or High Risk
of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry.
Journal of Cardiac Failure. 2024; 30: [DOI: 10.1016/j.cardfail.2024.08.048]. Epub Sep 12,
2024.
PDF PubMed
Hilgarth, H., Gradl, G., Metzger, N., Dörje, F., Schulz, M., Wolf, C. and Seidling, H.M.;
für die ADKA-DPhG Arbeitsgruppe Entlassmanagement / Entlassrezepte (Collaborators):
EINSATZ VON EntlassrezeptEN. ein überblick AUS
DEUTSCHLAND FÜR die jahre 2018 bis 2021
[The utilization of discharge prescriptions in Germany—an overview for the years 2018–2021].
Deutsches Arzteblatt International. 2024; 121 (16): 539–540 [DOI: 10.3238/arztebl.m2024.0095]. Epub Aug 9, 2024.
PDF (EN) PDF (DE) PubMed
Götzinger, F., Kieble, M, Espinosa Daudí, A., Kunz, M., Lauder, L., Böhm, M., Laufs, U., Mahfoud, F. and Schulz, M.:
Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023:
a nationwide population-based study.
Journal of Hypertension. 2024; 42 (10): 1720–1727 [DOI:
10.1097/HJH.0000000000003789]. Epub June 12, 2024.
Report in PZ online Pharmazeutische Zeitung. 2024;
Journal
PubMed
Arnet, I., Eickhoff, C., Sahm, L.J., Caloz, S., Mittag, M., Schulz, M. and Allemann, S.S.:
INCONCLUSIVENESS OF PSYCHOMETRIC TESTING OF MEDICATION ADHERENCE QUESTIONNAIRES.
European Journal of Clinical Pharmacology. 2024; 80 (8):
1189–1195 [DOI: 10.1007/s00228-024-03684-8]. Epub April 22, 2024.
PDF PubMed
Rohr, B.S., Krohmer, E., Foerster, K.I., Burhenne, J., Schulz, M., Blank, A., Mikus, G., Haefeli, W.E.:
Time course of the interaction between oral short-term ritonavir therapy with three
factor Xa inhibitors and the activity of CYP2D6, CYP2C19, and CYP3A4 in healthy volunteers.
Clinical Pharmacokinetics. 2024; 63 (4): 469–481 [DOI: 10.1007/s40262-024-01350-x].
Epub Feb 23, 2024.
PDF
PubMed
2023
Messner, K., Eickhoff, C., Schulz, M., Allemann, S. and Arnet,
I.:
KNOWLEDGE AND ATTITUDES OF GERMAN AND SWISS COMMUNTY PHARMACISTS TOWARDS BIOLOGICALS
AND BIOSIMILARS – A PROSPECTIVE SURVEY BEFOR AND AFTER THE COVID-19
PANDEMIC.
BMC Health Services Research. 2023; 23: 1432 [DOI: 10.1186/s12913-023-10475-x]. Epub Dec 18, 2023.
PDF PubMed
Kunz, M., Götzinger, F., Jacobs, C.M., Lauder, L., Ukena, C., Meyer, M.R., Laufs. U., Schulz, M., Böhm, M. and Mahfoud, F.:
HIDDEN Sodium IN EFFERVESCENT-TABLET dietary supplementS and over-the-counter
DRUGS – A comparative cross-sectional study.
BMJ Open. 2023; 13: e076302 [DOI: 10.1136/bmjopen-2023-076302]. Epub Nov 27, 2023.
Report in, among others: Pharmazeutische Zeitung. 2023; 168 (51-52): 3547.
PDF PubMed
Brockamp, C., Landgraf, R., Müller, U.A., Müller-Wieland, D., Petrak, F., Uebel, T.;
the National Disease Management Guideline
Group (Krueger, M., Schulz, M., et al.):
SHARED DECISION MAKING, DIAGNOSTIC EVALUATION, AND PHARMACOTHERAPY IN TYPE 2 DIABETES:
NATIONAL DISEASE MANAGEMENT GUIDELINE
[Partizipative Entscheidungsfindung, Diagnostik und medikamentöse Therapie bei Typ-2-Diabetes. Nationale VersorgungsLeitlinie].
Deutsches Arzteblatt International. 2023; 120 (47): 804–810 [DOI: 10.3238/arztebl.m2023.0219]. Epub Nov
24, 2023.
PDF PubMed
Arnet, I., Sahm, L.J., Gregório J., Tuula, A., Krueger, M., Wurmbach, V., Kreshnik, H.,
Schulz, M. and Eickhoff, C.:
Development and validation of the 15-STARS - a novel self-report
PHARMACY-BASED questionnaire to screen for medication non-adherence.
Research in Social and Administrative Pharmacy. 2024; 20 (3):
308–320 [DOI: 10.1016/j.sapharm.2023.11.005].
Epub Nov 24, 2023.
Report in: Life Science Network.
PDF PubMed
Kerwagen,
F., Riemer, U., Wachter, R., von Haehling, S., Abdin, A., Böhm, M., Schulz, M. and Störk, S.:
impact of the COVID-19 pandemic ON IMPLEMENTATION of novel guideline-directed
medical therapies for heart failure in germany: a nationwide retrospective analysis.
The Lancet Regional Health –
Europe. 2023; 35: 100778 [DOI: 10.1016/j.lanepe.2023.100778]. Epub Nov 11, 2023.
PDF PubMed
Eickhoff, C., Müller, U., Thomas, S., Schmidt, C., Hartling, L.-S., Michael, S., Schulz, M. and Bertsche, T.:
patients’ USE OF A STANDARDIZED MEDICATION LIST – A mixed methods study.
Patient Preference and Adherence. 2023; 17: 2655–2666 [DOI: 10.2147/PPA.S427192]. Epub Oct 30, 2023.
Report in: Pharmazeutische Zeitung. 2023; 168 (46): 3166.
PDF PubMed
Neubert, A., Toni, I., König, J., Malonga Makosi, D,. Mildenberger, P., Romanos, M., Bertsche, A., Bertsche, T., Dahlem, P., Egberts, K., Erdlenbruch, B., Fekete,
S., Haug, U., Horneff, G., Hübler, A., Kiess, W., Neininger, MP., Niehues, T., Sachs, B., Schettler, K.F., Schreeck, F., Steimle, T., Wenzl, T., Wirth, S., Zepp, F., Schwab ,M., Urschitz, M.S.,
Rascher, W.; KiDSafe Consortium (Schulz, M. …):
A Complex Intervention to Prevent Medication-Related Hospital Admissions.
Deutsches Arzteblatt International. 2023; 120 (25): 425–431 (DOI: 10.3238/arztebl.m2023.0123).
PDF PubMed
Schulz, M. and Laufs, U.:
Not obtaining a medication the first time it is prescribed: primary non-adherence to
cardiovascular pharmacotherapy.
Clinical Research in Cardiology. 2024; 113 (8): 1103–1116 [DOI: 10.1007/s00392-023-02230-3]. Epub May 20, 2023.
Report in: Pharmazeutische Zeitung. 2023; 168 (35): 2342–2343.
PDF PubMed
Bertsche, T., Alexa J. M., Eickhoff, C. and Schulz, M.:
Self-care AND SELF-MEDICATION as central componentS of healthcare in Germany – On the way
to evidence-based pharmacy.
Exploratory Research in
Clinical and Social Pharmacy. 2023; 9 (3):
100257 [DOI: 10.1016/j.rcsop.2023.100257].
Epub April 12, 2023.
PDF PubMed
Götzinger, F., Wilke, T., Hardtstock, F., Krieger, J., Maywald, U., Kunz, M., Lauder, L., Schulz, M., Mahfoud, F. and Böhm,
M.:
association of hydrochlorothiazide treatment compared to alternative diuretics with overall
and skin cancer risk: a propensity-matched cohort study.
Journal of Hypertension. 2023; 41 (6): 926–933 [DOI: 10.1097/HJH.0000000000003414]. Epub March 10, 2023.
Report in: Pharmazeutische
Zeitung. 2023; 168 (15): 1012.
Enners, S., Gradl, G., Kieble, M., Iliescu, O., Freudewald, L., Said, A. and Schulz, M.:
Increased demand for pharmaceutical drugs containing potassium iodide in connection
with the Russia-Ukraine conflict.
Pharmazie. 2023; 78 (1): 17–19 [DOI: 10.1691/ph.2023.2541].
PDF PubMed
Gehrke-Beck, S., Petersen, M. Herrmann, W.J., Zimmermann, N., Daub, E., Seeger, J., Schulz, J., Czimmeck, C., Lauterbach, N.,
Peters, H., Kloft, C., Schulz, M., Siebenbrodt, I. and Behrend, R.:
Development of a
project for interprofessional collaboration between medical and pharmacy
students to improve medication safety in polypharmacy (PILLE).
[Entwicklung eines Lehrprojekts zur interprofessionellen Zusammenarbeit von Medizin- und Pharmaziestudierenden zur
Verbesserung der Arzneimitteltherapiesicherheit bei Polypharmazie (PILLE)].
GMS Journal for Medical Education. 2023; 40 (1): Doc3 [DOI: 10.3205/zma001585]. Epub Feb 15, 2023.
PDF PubMed
2022
Gradl, G., Kieble, M., Nagaba, J. and
Schulz, M.:
Assessment of the prescriptions of systemic antibiotics in primary dental care in Germany
from 2017 to 2021: A Longitudinal Drug Utilization StuDy.
Antibiotics.
2022; 11 (12):
1723 [DOI: 10.3390/antibiotics11121723]. Epub Nov 30, 2022.
PDF
Schulz, M., Griese-Mammen, N. and Müller, U.:
Clinical pharmacy services are reimbursed in germany – Challenges of real world
implementation remain (Commentary).
International
Journal of Clinical Pharmacy. 2023; 45 (1): 245-249 [DOI: 10.1007/s11096-022-01492-7]. Epub Nov 17, 2022.
Report in: Pharmazeutische Zeitung. 2022; 167 (48): 3264.
PDF PubMed
Moecker, R., Fuchs, A., ARMIN Study Group*, Haefeli, W.E., Weissenborn, M. and Seidling, H.M.:
ATTITUDES OF NON-PARTICIPATING GENERAL Practitioners and community pharmacists
Towards interprofessional medication management in primary care. An interview study.
International Journal of Clinical Pharmacy. 2022; 44 (6): 1380–1393
[DOI: 10.1007/s11096-022-01434-3]. Epub Oct 8, 2022.
(*Eickhoff, C., Mueller, U., Schulz, M., Braun, D., Maywald. U., Doehler, C., Maetzler, M., Auerbach, A., Kuhn, U.D.,
Moeckel, A., Honscha, C., Donner, S., Fink, S., Wagner, K., Meid, A.D., Ruff, C., Stoll, F., Wirbka, L.)
PDF PubMed
Moecker, R., Weissenborn, M., Klingenberg, A., Wirbka, L., Fuchs, A., Eickhoff, C., Mueller, U., Schulz, M.,
Kaufmann-Kolle, P., ARMIN Study Group, Haefeli, W.E. and Seidling, H.M.:
Task sharing in an interprofessional medication
management program – a survey of
general practitioners and community pharmacists.
BMC Health Services Research. 2022; 22 (1): 1005 [DOI:
10.1186/s12913-022-08378-4]. Epub Aug 6, 2022.
Reports in: Pharm Ztg. DAZ.online aerztebl.de Dtsch Arztebl. 2022; 119 (35-36): A-1446.
PDF PubMed
Abdin, A., Schulz, M., Riemer, U., Hadëri, B., Wachter, R, Laufs, U., Bauersachs, J., Kindermann, I.,
Vukadinović, D. and Böhm, M.:
Sacubitril/valsartan in heart failure: Efficacy and safety in and outside clinical
trials.
ESC Heart Failure. 2022; 9 (6): 3737–3750 [DOI: 10.1002/ehf2.14097]. Epub Aug 3, 2022.
Report in: Cardio News 2022; 25 (11/12): 52.
PDF PubMed
Katzmann, J.L., Kieble, M., Enners, S., Böhm, M., Mahfoud, F., Laufs, U. and Schulz, M.:
Trends in ezetimibe prescriptions as monotherapy or fixed-dose combination
in Germany 2012–2021.
Frontiers in Cardiovascular Medicine. 2022; 9:
912785 [DOI: 10.3389/fcvm.2022.912785].Epub June 13, 2022.
Report in: Pharmazeutische Zeitung. 2022, June 16.
PubMed
Koehler, F., Störk, S. and Schulz, M.:
telemonitoring of heart failure patients is
reimbursed in germany – Challenges of
real world implementation remain (Letter).
European Heart Journal – Digital Health. 2022; 3 (2): 121–122
[DOI: 10.1093/ehjdh/ztac017]. Epub April 19, 2022.
PDF
Mikus, G., Foerster, K.I., Terstegen, T., Vogt, C., Said, A., Schulz, M. and Haefeli,
W.E.:
Oral drugs against COVID-19 – management of drug
interactions with the
use of nirmatrelvir/ritonavir
[Orale Pharmakotherapie bei COVID-19 – Wechselwirkungsmanagement beim Einsatz von Nirmatrelvir/Ritonavir].
Deutsches Arzteblatt International. 2022; 119 (15): 263–269 [DOI: 10.3238/arztebl.m2022.0152]. Epub March 16, 2022.
PDF
PubMed
EN
Mahfoud, F., Kieble, M., Enners, S., Kintscher, U., Laufs, U., Böhm, M. and Schulz, M.:
Use of fixed-dose combination antihypertensives in Germany between 2016 AND 2020:
an example of guideline inertia.
Clinical Research in Cardiology. 2023; 112 (2): 197–202 [DOI: 10.1007/s00392-022-01993-5]. Epub Feb 27,
2022.
PDF PubMed
Reports in: Pharmazeutische Zeitung. 09.03.2022; aerzteblatt.de, 13.04.2022; MTA Dialog, 13.04.22; idw, 1204.2022
Koehler, F. and Schulz, M.:
The AMULET ménage à trois: nurse, telemedicine support, and
remote cardiologist (Editorial Comment).
European Journal of Heart Failure. 2022; 24 (3):
578–580 [DOI: 10.1002/EJHF.2437].
Epub Jan 21, 2022.
PDF PubMed
Eickhoff, C., Müller, U., Seidling, H.M., Lampert, A., Botermann, L., Strunz, A.K. and Schulz, M.:
patientS’ perception on generating medication plans in an interProfessional medication
management PROGRAM: A mixed-methods study.
Journal of
Interprofessional Care. 2022; 36 (5): 770–775 [DOI: 10.1080/13561820.2021.1994935]. Epub Jan 3, 2022.
PDF PubMed
Reports in: Pharmazeutische Zeitung. 2022; 167 (7): 408
and Deutsche Apotheker Zeitung. 2022; 162 (8): 622.
DAZ.online,
18.02.2022.
2021
Arnet, I., Verbeek, M., Almarsdóttir, A.B., Barbier, L., Clifford, R., Eickhoff, C., Hersberger, K., Huys, I., Lee, K.,
Saramunee, K., Schulz, M., Zgarrick, D., Sarnola, K.:
Community pharmacists’ preparedness for substituting biologics and dispensing
biosimilars – lessons learned from a multinational survey.
Exploratory Research in Clinical and Social
Pharmacy. 2021; 4 (Dec.): 100084 [DOI: 10.1016/j.rcsop.2021.100084].
Epub Oct 22, 2021.
PDF
Schumacher, P.M., Griese-Mammen, N., Schneider, J., Laufs, U. and Schulz, M.:
INTERDISCIPLINARY PHYSICIAN-PHARMACIST MEDICATION REVIEW FOR OUTPATIENTS WITH HEART
FAILURE:
A SUBANALYSIS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
Frontiers in Pharmacology. 2021; 12: 712490 [DOI: 10.3389/fphar.2021.712490]. Epub Sep 7, 2021.
PDF PubMed
Enners, S., Gradl, G., Kieble, M., Böhm, M., Laufs, U. and Schulz, M.:
UTILIZATION OF DRUGS WITH REPORTS ON POTENTIAL EFFICACY OR HARM ON COVID-19 BEFORE, DURING, AND
AFTER THE FIRST PANDEMIC WAVE.
Pharmacoepidemiology and Drug Safety. 2021; 30 (11): 1493–1503 [DOI: 10.1002/pds.5324]. Epub July 9, 2021.
Among the Top Cited Articles 2021–2022.
Report in: Pharmazeutische Zeitung. 2021; 166 (31): 2278.
PDF PubMed
Schumacher, P.M., Becker, N., Griese-Mammen, N., Tsuyuki, R.T., Koshman, S.K., McDonald, M.A., Bouvy, M., Rutten, F.H.,
Laufs, U., Böhm, M. and Schulz, M.:
THE EVIDENCE FOR PHARMACIST CARE IN OUTPATIENTS WITH HEART FAILURE:
A SYSTEMATIC REVIEW AND META-ANALYSIS.
ESC Heart Failure. 2021; 8 (5):
3566–3576 [DOI: 10.1002/ehf2.13508]. Epub July 8, 2021.
Report in Pharmazeutische Zeitung. 2021; 166 (37): 2679–2680.
PDF PubMed
Gradl, G., Werning, J., Enners, S., Kieble, M. and Schulz, M.:
Quality appraisal of AMBULATORY oral cephalosporin and fluoroquinolone use in
the 16 German federal states from 2014–2019.
Antibiotics. 2021; 10 (7): 831 [DOI:
10.3390/antibiotics10070831]. Epub July 8, 2021.
Report in Pharmazeutische Zeitung. 2021; 166 (32): 2336.
PDF PubMed
Said, A., Freudewald, L., Parrau, N., Ganso, M. and Schulz, M.:
Pharmacists’ perception of educational material TO IMPROVE PATIENT SAFETY:
A CROSS-SECTIONAL sTuDy on practices and awareness IN GERMANY.
Medicine. 2021; 100 (11): e25144 [DOI: 10.1097/MD.0000000000025144]. Epub March 19, 2021.
PDF PubMed
Rüsenberg, R., Baumgarten, A., Mauss, S., Gradl, G., Schulz, M., Bartmeyer, B., Kollan, C. and Schmidt, D.:
WIE WIRKEN GENERIKAQUOTEN? EINE ANALYSE AM BEISPIEL HIV
[How do generic quotas work? An analysis using HIV
infection as an e example].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021; 64 (5): 625–634.
[DOI: 10.1007/s00103-021-03312-1]. Epub April 14, 2021.
PDF PubMed
2020
Moorkens, E., Barcina, T., Vulto, A.G., Schulz, M., Gradl, G., Enners, S., Selke,
G., Huys, I. and Simoens, S.:
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany.
Pharmaceuticals. 2020; 13 (10): 324 [DOI: 10.3390/ph13100324]. Epub Oct 21, 2020.
PDF PubMed
Rudolph, U., Enners, S., Kieble, M., Mahfoud, F., Böhm, M., Laufs, U. and Schulz, M.:
IMPACT of Angiotensin Receptor Blocker Product Recalls ON ANTIHYPERTENSIVE PRESCRIBING in Germany.
Journal of Human Hypertension. 2020; 35: 903–911 [DOI:
10.1038/s41371-020-00425-z]. Epub Oct 14,
2020.
PDF PubMed
Schulz, M., Griese-Mammen, N., Schumacher,, P.M., Strauch, D., Freudewald, L., Said, A., Tsuyuki, R.T., Laufs, U.,
Kintscher, U., Böhm, M. and Mahfoud, F.:
Development and Implementation of Blood Pressure Screening and Referral Guidelines
for German Community Pharmacists.
Journal of Clinical Hypertension. 2020; 22 (10): 1807–1816 [DOI: 10.1111/JCH.14020]. Epub Aug 30, 2020.
JCH PDF Suppl Fig S1 Suppl Fig S3 PubMed
Garcia Cardenas, V., Rossing, C., Fernandez-Llimos, F., Schulz, M., Tsuyuki, R.T., Bugnon, O., Tonin, F. and Benrimoj,
S.I.:
PHARMACY PRACTICE RESEARCH – A CALL TO ACTION.
Research in Social and Administrative Pharmacy. 2020; 16 (11): 1602–1608 [DOI: 10.1016/j.sapharm.2020.07.031].
Epub Aug 4, 2020.
RSAP PubMed
Mahfoud, F., Kieble, M.,
Enners, S., Werning, J., Laufs, U., Millenaar, D., Böhm, M., Kintscher, U. and Schulz, M.:
ROTE-HAND-BRIEF ZU HYDROCHLOROTHIAZID UND VERORDNUNG VON ANTIHYPERTENSIVA
[„Dear Doctor“ warning letter (Rote-Hand-Brief) on hydrochlorothiazide and antihypertensive prescribing].
Deutsches Ärzteblatt
International. 2020; 117: 687–688 [DOI: 10.3238/arztebl.2020.0687].
PDF PubMed
Schulz,
M., Griese-Mammen, N., Schumacher, P.M., Anker, S.D., Koehler, F., Ruckes, C., Rettig-Ewen, V., Wachter, R.,
Trenk, D., Böhm, M. and Laufs, U.:
THE IMPACT OF PHARMACIST/PHYSICIAN CARE ON QUALITY OF LIFE IN ELDERLY HEART FAILURE PATIENTS:
RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
ESC Heart Failure. 2020; 7 (6):
3310–3319 [DOI:10.1002/ehf2.12904].
Epub July 23, 2020.
PDF PubMed
Schulz, M., Schmoldt,
A., Andresen-Streichert, H. and Iwersen-Bergmann, S.:
REVISITED: THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 1,100 DRUGS AND
OTHER XENOBIOTICS.
Critical
Care. 2020; 24 (1): 195 [DOI: 10.1186/s13054-020-02915-5]. Epub May 6, 2020
[12k Article Accesses as of 18 November 2023].
PDF Suppl. File
PubMed
2019
Schönfeld, T., Heineman, A., Schulz, M., Gradl, G., Andresen-Streichert, H., Müller, A. and
Iwersen-Bergmann, S.:
POST-MORTEM ANALYSIS OF PRESCRIPTION OPIOIDS - A FOLLOW-UP EXAMINATION BY LC-MS/MS WITH
FOCUS ON FENTANYL.
Forensic Science International. 2019; 305: 109970 [DOI: 10.1016/j.forsciint.2019.109970]. Epub Oct 9, 2019.
Forensic Sci Int PubMed
Said, A., Ganso, M., Freudewald, L. and Schulz, M.:
Trends in dispensing oral emergency contraceptives and safety issues:
a survey of German community pharmacists.
International Journal of Clinical Pharmacy. 2019; 41 (6): 1499–1506; [DOI: 10.1007/s11096-019-00911-6]. Epub Sep 28, 2019.
IJCP PDF Suppl. Material PubMed
Hofmann, G. A.,
Gradl, G., Schulz, M., Haidinger, G., Tanew, A. and Weber, B.:
The frequency of photosensitizing drug dispensings in Austria and Germany: A coRRELATION
WITH THEIR PHOTOSENSITIZING POTENTIAL BASED ON PUBLISHED LITERATURE.
Journal of the European
Academy of Dermatology and Venereology. 2020; 34 (3): 589–600 [DOI:
10.1111/jdv.15952].
Epub Sep 14, 2019.
PDF PubMed Wiley
Schulz, M., Griese-Mammen, N., Böhm, M. and Laufs, U.:
Letter on ‘PHARMACY-BASED INTERDISCIPLINARY INTERVENTION FOR PATIENTS WITH CHRONIC HEART FAILURE:
RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL': REPLY.
European Journal of Heart Failure. 2020; 22 (3): 565–566 [DOI: 10.1002/ejhf.1613]. Epub Sep 16, 2019.
Schulz, M., Griese-Mammen, N.,
Anker, S.D., Koehler, F., Ihle, P., Ruckes, C., Schumacher, P.M., Trenk, D., Böhm, M. and Laufs, U.
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure:
results of the PHARM-CHF randomized controlled trial.
European Journal of Heart Failure. 2019; 21 (8): 1012–1021 [DOI: 10.1002/ejhf.1503). Epub May 25, 2019.
PubMed
EJHF PDF Suppl. Material
Eickhoff, C., Müller, U., Strunz, A.K., Seidling, H.M.,
Lampert, A., Felberg, M., Breiholz, S., Klintworth, D. and Schulz, M.:
Das Projekt PRIMA -
Elektronische Erstellung und Aktualisierung von Medikationsplänen als
gemeinsame Aufgabe von Ärzten und Apothekern
[The PRIMA project - electronically-supported physician-pharmacist co-operation to generate
and update medication plans in Germany].
Deutsche Medizinische Wochenschrift 2019;
144 (18): e114–e120 [DOI: 10.1055/a-0859-5862]. Epub March 29, 2019.
PubMed
PDF
Ihle, P., Krueger, K., Schubert, I. Griese-Mammen, N.,
Parrau, N., Laufs, U. and Schulz, M.:
Comparison of different strategies to measure medication adherence via claims data in patients
with chronic heart failure.
Clinical Pharmacology & Therapeutics. 2019; 106 (1): 211–218 [DOI: 10.1002/cpt.1378]. Epub Jan 29, 2019.
PubMed
PDF
Breiholz, S., Griese-Mammen, N., Krueger, K., Schaefer, M. and Schulz, M.:
Acceptance of a Medication Refill Reminder Service in GERMAN Community Pharmacy Practice.
Pharmazie. 2019; 74 (3): 186–190 [DOI: 10.1691/ph.2019.8669].
PubMed
Katzman, J., Mahfoud, F., Böhm, M., Schulz, M. and Laufs, U.:
ASSOCIATION OF MEDICATION ADHERENCE AND DEPRESSION WITH CONTROL OF LDL CHOLESTEROL AND BLOOD PRESSURE IN PATIENTS WITH HIGH CARDIOVASCULAR
RISK.
Patient Preference and Adherence. 2019; 13: 9–19. [DOI: 10.2147/PPA.S182765]. Epub Dec 18, 2018.
PubMed PDF
2018
Said, A., Goebel, R., Ganso, M., Zagermann-Muncke, P. and Schulz, M.:
Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of
the Drug Commission of German Pharmacists.
Health Policy. 2018; 122 (12):1302–1309 [DOI: 10.1016/j.healthpol.2018.09.005]. Epub Sep 13, 2018.
PubMed
Gradl, G., Teichert, M., Kieble, M., Werning, J. and Schulz, M.:
COMPARING OUTPATIENT ORAL ANTIBIOTIC USE IN GERMANY AND THE NETHERLANDS FROM 2012 TO 2016.
Pharmacoepidemiology and Drug Safety. 2018; 27 (12): 1344–1355 [DOI: 10.1002/pds.4643]. Epub Sep 28, 2018.
PubMed PDF
Müller, U., Schulz, M., and Mätzler, M.:
Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung
der Arzneimitteltherapiesicherheit. Die Arzneimittelinitiative Sachsen-Thüringen (ARMIN)
[Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting. The “Arzneimittelinitiative Sachsen-Thüringen”
(ARMIN)].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 61
(9): 1119–1128
[DOI: 10.1007/s00103-018-2780-5]. Epub July
30, 2018.
PubMed
PDF
Dormann, H., Maas, R., Eickhoff, C., Müller, U., Schulz, M., Brell, D. and Thürmann, P.:
ERPROBUNG DES BUNDESEINHEITLICHEN MEDIKATIONSPLANS IN DER PRAXIS: DIE PILOTPROJEKTE
METROPOLMEDIPLAN 2016, MODELLREGION ERFURT UND PRIMA
[Testing the standardized medication plan: the pilot projects MetropolMediplan 2016, model region Erfurt and PRIMA].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61
(9): 1093–1102
[DOI: 10.1007/s00103-018-2789-9]. Epub July 25,
2018.
Laufs, U., Griese-Mammen, N., Krueger, K., Wachter, A., Anker, S.D., Koehler, F.,
Rettig-Ewen, V., Botermann, L., Strauch, D.,
Trenk, D., Böhm, M. and Schulz, M.:
PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial and
results of the pilot study.
European Journal of Heart Failure. 2018; 20 (9):
1350–1359 [DOI: 10.1002/ejhf.1213]. Epub May 30,
2018.
Weißenborn, M., Schulz, M., Kraft, M., Haefeli, W.E. and Seidling, H.M. :
Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische
Übersicht
[Potential benchmarks for successful interdisciplinary collaboration projects in Germany: a systematic review].
Gesundheitswesen. 2019;
81 (12): 1057–1068
[DOI: 10.1055/a-0592-7184]. Epub June 21, 2018.
PubMed Gesundheitswesen
2017
Felberg, M., Reckers, K., Schulz, M. and Scherneck, S.:
DER DIABETOLOGISCH QUALIFIZIERTE APOTHEKER DDG. EVALUATION EINER PRAXISORIENTIERTEN
INTENSIV-FORTBILDUNG
[Community pharmacist care of patients with diabetes: opportunities and limitations].
Medizinische
Monatsschrift für Pharmazeuten. 2017; 40 (11): 496–501.
Botermann, L., Wachter, A., Monzel, K., Krueger, K., Ewen, S., Mahfoud, F., Griese-Mammen, N.,
Schulz, M. and Laufs, U.:
Do patients with diabetes type 2 or chronic heart failure understand a medication plan?
Pharmazie. 2017; 72 (12): 764–768 [DOI: 10.1691/ph.2017.7773].
PubMed
Krueger, K., Griese-Mammen, N., Schubert, I., Kieble, M., Botermann, L., Laufs, U., Kloft, C.
and Schulz, M.:
IN SEARCH OF A STANDARD WHEN ANALYZING
MEDICATION ADHERENCE IN PATIENTS WITH HEART FAILURE
USING CLAIMS DATA: A SYSTEMATIC REVIEW.
Heart Failure
Reviews. 2018; 23 (1): 63–71 [DOI:
10.1007/s10741-017-9656-x]. Epub Oct 9, 2017.
PubMed Full text
Schulz, M. et al. / BÄK, KBV, AWMF, AMK et al. (eds.):
National Disease Management Guideline CHRONIC HEART FAILURE
(Nationale VersorgungsLeitlinie [NVL] chronische Herzinsuffizienz).
2nd
edition 2017.
2016
Schulz, M., Goebel, R., Schumann, C. and Zagermann-Muncke, P.:
Non-prescription dispensing of emergency oral contraceptives: Recommendations from the
German Federal Chamber of Pharmacists [Bundesapothekerkammer].
Pharmacy Practice (Granada). 2016; 14 (3): 828 [DOI: 10.18549/PharmPract.2016.03.828].
PubMed Full
text
Custodis, F., Rohlehr, F., Wachter, A., Böhm, M., Schulz, M. and Laufs, U.:
Medication knowledge of patients hospitalized for heart failure at
admission and after discharge.
Patient Preference and Adherence. 2016; 10: 2333–2339 [DOI: 10.2147/PPA.S113912].
PubMed
Full text
Gradl, G., Krieg, E.-M. and Schulz, M.:
EVALUATION OF PHARMACEUTICAL CONCERNS IN GERMANY: FREQUENCY AND POTENTIAL REASONS.
Pharmacy Practice (Granada). 2016; 14 (3): 786 [DOI: 10.18549/PharmPract.2016.03.786].
PubMed Full text Suppl. Material
Schulz, M.,
Krueger, K., Schuessel, K., Friedland, K., Laufs, U., Müller, W.E. and Ude, M.:
MEDICATION ADHERENCE AND Persistence according to DIFFERENT antihypertensive drug classES:
A RETROSPECTIVE cohort STUDY of 255,500 patients.
International Journal of Cardiology. 2016; 220: 668–676 [DOI:
10.1016/j.ijcard.2016.06.263]. Epub June 29, 2016.
PubMed IJC Full text
Ganso, M., Goebel, R., Melhorn, S., Schrenk, D. and Schulz, M.:
Lipidpneumonie durch LIPID-haltige Nasensprays und -tropfen
[Lipoid pneumonia associated with lipid-containing nasal sprays and nose
drops].
Laryngo-Rhino-Otologie. 2016; 95 (8): 534–539 [DOI: 10.1055/s-0042-108445]. Epub Aug 9, 2016.
PubMed Full text
Botermann, L., Monzel, K., Krueger, K., Eickhoff, C., Wachter, A., Kloft, C., Laufs, U. and
Schulz, M.:
evaluating PATIENTS’ COMPREHENSIBILITY of a standardized medication plan.
European Journal of Clinical Pharmacology. 2016; 72 (10):
1229–1237 [DOI: 10.1007/s00228-016-2082-5]. Epub June 15, 2016.
PubMed EJCP
Botermann, L., Krueger, K., Eickhoff, C., Kloft, C. and
Schulz, M.:
PATIENT’S HANDLING OF A STANDARDIZED MEDICATION PLAN: A PILOT STUDY AND METHOD DEVELOPMENT.
Patient Preference and Adherence. 2016; 10: 621–630 [DOI: 10.2147/PPA.S96431]. Epub April 22, 2016.
PubMed Full text
van Mil, J.W.F., Westerlund, T., Brown, L., Chen, T.F., Henman, M., Hersberger, K.,
McElnay, J. and Schulz,
M.:
MEDICAL CARE AND DRUG-RELATED PROBLEMS: DO DOCTORS AND PHARMACISTS SPEAK THE SAME LANGUAGE?
International Journal of Clinical Pharmacy. 2016; 38 (2): 191–194, erratum 195; [DOI: 10.1007/s11096-016-0249-x].
Epub Jan 21, 2016.
PubMed
Full text Erratum
2015
Krueger, K., Botermann, L., Schorr, S.G., Griese-Mammen, N., Laufs, U. and Schulz,
M.:
Age-related
medication adherence in patients with chronic heart failure: a systematic literature review.
Int. J.
Cardiol. 2015; 184: 728-735 [DOI: 10.1016/j.ijcard.2015.03.042]. Epub
March 4, 2015.
Abstract IJC PubMed
Full text Suppl. material
Schulz, M., Meins, J., Diemert, S., Zagermann-Muncke, P., Goebel, R., Schrenk, D., Schubert-Zsilavecz, M. and Abdel-Tawab, M.:
Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas.
Phytomedicine. 2015; 22 (6): 648-656 [DOI: 10.1016/j.phymed.2015.03.020]. Epub April 29, 2015.
ScienceDirect PubMed Full text
Hansen, K., Schüssel, K., Kieble, M., Werning, J., Schulz, M., Friis, R., Pöhlau, D., Schmitz, N. and Kugler, J.:
Adherence to disease modifying drugs among patients with multiple sclerosis in Germany: A retrospective cohort
study.
PLoS One 2015; 10 (7): e0133279 [DOI:
10.1371/journal.pone.0133279.]. Epub July 27, 2015.
PubMed
Full
text
2014
Saverno, K., Gothe, H., Schüssel, K., Biskupiak, J.E., Schulz, M., Siebert, U. and
Brixner, D.:
Consideration of International Generic Distribution Policies on Patient Outcomes in the United States and Germany.
Pharmazie. 2014; 69 (3): 238-240 [DOI:
10.1691/ph.2014.3786].
PubMed
Schorr, S.G., Eickhoff, C., Feldt, S., Hohmann, C. and Schulz, M.:
EXPLORING THE potential impact of hospital ward-based pharmacy interns on drug safety.
Pharmazie. 2014; 69 (4): 316-320 [DOI:
10.1691/ph.2014.3848].
PubMed
Ewen, S., Baumgarten, T., Rettig-Ewen, V., Mahfoud, F., Griese-Mammen, N., Schulz, M., Böhm, M. and
Laufs, U.:
Analyses of drugs
stored at home by elderly patients with chronic heart failure.
Clin. Res. Cardiol. 2015;
104 (4): 320-327 [DOI:
10.1007/s00392-014-0783-2]. Epub November 6, 2014.
PubMed
Full text
Fikenzer, K., Knoll, A., Fischer, D., Schulz, M., Böhm, M. and Laufs, U.:
Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und kardialer
Dekompensation.
[Poor medication adherence and worsening heart failure - a vicious circle].
Dtsch. Med. Wochenschr.
2014; 139 (47): 2390-2394
[DOI: 10.1055/s-0034-1387391]. Epub November 12, 2014.
PubMed Full
text
2013
Ude, M., Leuner, K., Schüssel, K., Schulz, M. and Müller, W.E.:
ADHERENCE TO ANTIHYPERTENSIVES: FEASIBILITY OF TWO SELF-REPORT INSTRUMENTS TO INVESTIGATE MEDICATION-TAKING BEHAVIOUR IN GERMAN COMMUNITY PHARMACIES.
Int. J. Pharm. Pract. 2013; 21 (3): 169-177 [DOI:
10.1111/j.2042-7174.2012.00248.x]. Epub October 29, 2012.
PubMed
Nicolas, A., Eickhoff, C.,
Griese, N. and Schulz, M.:
drug-related problems in prescribed medicines IN GermanY at the time OF dispensING.
Int. J. Clin. Pharm. 2013; 35 (3): 476-482 [DOI:
10.1007/s11096-013-9769-9]. Epub April 20, 2013.
PubMed
Czeche, S., Schüssel, K., Franzmann, A., Burkart, M. and Schulz, M.:
DOSAGE STRENGTH IS ASSOCIATED WITH MEDICATION PERSISTENCE WITH GINGKO BILOBA DRUG PRODUCTS.
BMC Complement. Altern. Med. 2013; 13 (1): 278 [DOI: 10.1186/1472-6882-13-278]. Epub October 24, 2013.
PubMed
Full text PDF
2012
Quinzler, R., Ude, M., Franzmann, A., Feldt, S., Schüssel, K., Leuner, K., Müller,
W.E., Dippel.F.-W. and Schulz, M.:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type 2 diabetic patients: comparison of insulin glargine with NPH
insulin.
Int. J. Clin. Pharmacol. Ther. 2012; 50 (1): 24–32.
PubMed
Eickhoff, C., Hämmerlein, A., Griese, N. and Schulz, M.:
Nature and frequency of drug-related problems in self-medicatioN (OVER-THE-COUNTER DRUGS) in daily community pharmacy practice in Germany.
Pharmacoepidemiol. Drug Saf. 2012; 21 (3): 254-260 [DOI:
10.1002/pds.2241]. Epub September 28, 2011.
PubMed
Hohmann, C., Eickhoff, C., Radziwill, R. and Schulz, M.:
Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals:
A multicenter evaluation involving pharmacy interns.
Infection 2012; 40 (2): 131–137 [DOI: 10.1007/s15010-011-0204-7]. Epub October 15, 2011.
PubMed
Feldt, S., Schüssel, K., Quinzler, R., Franzmann, A., Czeche, S., Ludwig, W.-D. and Schulz, M.:
INCIDENCE OF THYROID HORMONE THERAPY IN PATIENTS TREATED WITH SUNITINIB OR SORAFENIB: A COHORT STUDY.
Eur. J. Cancer 2012; 48 (7): 974-981
[DOI:10.1016/j.ejca.2012.01.036]. Epub February 28, 2012.
PubMed Full text
Schulz, M., Iwersen-Bergmann, S., Andresen, H. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD
CONCENTRATIONS OF NEARLY 1,000 DRUGS AND OTHER XENOBIOTICS.
Critical Care 2012; 16: R136 [DOI:10.1186/cc11441]. Epub July 26, 2012.
[28k Article Accesses].
PubMed
Full text (including suppl. material) Additional file 1
2011
Krüger, M., Griese, N. and Schulz, M.:
Medikationsmanagement für Menschen mit Diabetes.
[Home medication review for patients with diabetes].
Diabetes Stoffw. Herz 2011; 20 (4): 219–226.
Online
Hohmann, C., Eickhoff, C., Kämmerer, W. and Schulz, M.:
Compliance with antithrombotic guidelines in surgery patients in German hospitals: A multicenter study involving pharmacy interns.
Clin. Appl. Thromb. Hemost. 2012; 18 (3): 299–304 [DOI: 10.1177/1076029611412368]. Epub July 6, 2011.
PubMed
Ude, M., Schüssel. K.,
Quinzler, R., Leuner, K., Müller, W.E. and Schulz, M.:
Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a
retrospective Study using the DAPI database.
J. Hypertens. 2011; 29 (9): 1837–1845 [DOI: 10.1097/HJH.0b013e32834942be]. Epub July 6, 2011.
PubMed
Hohmann, C. Eickhoff, C., Klotz, J.M., Schulz, M. and Radziwill, R.:
DEVELOPMENT OF A CLASSIFICATION SYSTEM FOR DRUG-RELATED PROBLEMS IN THE HOSPITAL SETTING (APS-Doc) AND ASSESSMENT OF THE INTER-RATER RELIABILITY.
J. Clin. Pharm. Ther. 2012; 37 (3): 276–281 [DOI: 10.1111/j.1365-2710.2011.01281.x]. Epub July 26, 2011.
PubMed
Laufs, U., Böhm, M., Kroemer, H.K., Schüssel, K., Griese, N. and Schulz, M.:
Strategien zur Verbesserung der Einnahmetreue von Medikamenten.
[Strategies to Improve Medication Adherence].
Dtsch. Med. Wochenschr. 2011; 136 (31-32): 1616–1621. Epub August 1, 2011.
PubMed
2010
Hämmerlein, A., Müller, U. and Schulz, M.:
VERSORGUNGSMANAGEMENT FÜR MENSCHEN MIT ASTHMA – EINBINDUNG DER APOTHEKER
[Involving pharmacists in the management of asthma
patients].
Z. Evid. Fortbild. Qual. Gesundh. wesen 2010; 104 (2): 92–98 [DOI : 10.1016/j.zefq.2009.07.007].
PubMed
Hämmerlein, A., Müller, U. and Schulz M.:
Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients.
J. Eval. Clin. Pract. 2011; 17 (1): 61–70 [DOI: 10.1111/j.1365-2753.2010.01369.x]. Epub Aug 30, 2010.
PubMed
2009
Hämmerlein, A. and Schulz, M.:
Co-authors of the German National Disease Management Guideline (Nationale VersorgungsLeitlinie (NVL)) ASTHMA, 2nd ed. 2009.
Eds.: Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
(AWMF).
Revision in: Dtsch. Ärztebl. 2011; 108 (11): A-596 / B-484 / C-484.
NVL Asthma
2008
Schüssel, K., Quinzler, R., Czeche, S. and Schulz, M.:
AKTUELLE VEORDNUNGEN VON COX-2-HEMMERN IN DEUTSCHLAND
[Contemporary precriptions of COX-2 inhibitors in Germany].
Internist. Praxis 2008; 48 (4): 837–850.
Full
text
2007
Gerdemann, A., Griese, N. and Schulz, M.:
PHARMACY INTERNS ON THE WARD – A PILOT STUDY.
Pharm. World Sci. 2007; 29 (1): 34–38 (DOI: 10.1007/s11096-005-5044-z].
PubMed
Rajska-Neumann, A., Wieczorowska-Tobis, K., Schulz, M., Breborowicz, A., Grzeskowiak, E. and Oreopoulos D.G.:
Duplicate use of angiotensin-converting enzyme (ACE) inhibitors in a community-dwelling elderly population in Poland.
Arch. Gerontol. Geriatr. 2007; 44 (Suppl. 1): 295–301.
PubMed
Bertsche, T., Hämmerlein, A. and Schulz, M.:
GERMAN NATIONAL DRUG INFORMATION SERVICE: USER SATISFACTION AND POTENTIAL POSITIVE PATIENT OUTCOMES.
Pharm. World. Sci. 2007; 29 (3): 167–172 [DOI: 10.1007/s11096-006-9041-7].
PubMed
Hämmerlein, A., Griese, N., and Schulz, M.:
Survey of Drug-related
Problems Identified by Community Pharmacies.
Ann. Pharmacother. 2007; 41 (11): 1825–1832 [DOI: 10.1345/aph.1K207].
PubMed
2006
Eickhoff, C. and Schulz, M.:
PHARMACEUTICAL CARE IN COMMUNITY PHARMACIES: PRACTICE AND RESEARCH IN GERMANY.
Ann. Pharmacother. 2006; 40 (4): 729–735 [DOI: 10.1345/aph.1G458].
PubMed
Schulz, M.,
Graefe, T., Stuby, K., Andresen, H., Kupfermann, N. and Schmoldt, A.:
Case report: Acute unintentional carbachol intoxication.
Critical Care 2006; 10: R84 [DOI:10.1186/cc4937].
Full text
Schulz, M., Hämmerlein, A., Hinkel, U., Weis, G. and Gillissen, A.:
SAFETY AND USAGE PATTERN OF AN OVER-THE-COUNTER AMBROXOL COUGH SYRUP:
A COMMUNITY PHARMACY-BASED COHORT STUDY.
Int. J. Clin. Pharmacol. Ther. 2006; 44 (9): 409–421.
PubMed
Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
EVALUATION DER DURCHFÜHRUNG VON GLUKOSESELBSTKONTROLLEN IN APOTHEKEN (EDGAr)
[Evaluation of self-monitoring of blood glucose in pharmacies - EDGAr].
Diabetes Stoffw. Herz 2006; 15
(4): 9–17.
Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
COMMUNITY PHARMACY-BASED INTERVENTION TO IMPROVE
SELF-MONITORING OF BLOOD GLUCOSE IN TYPE 2 DIABETIC PATIENTS.
Pharmacy Practice (Granada). 2006; 4 (4): 195–203.
Full
text
Schuessel, K. and Schulz, M.:
PRESCRIBING OF COX-2-INHIBITORS IN GERMANY AFTER SAFETY WARNINGS AND MARKET WITHDRAWALS.
Pharmazie. 2006; 61
(10): 878–886.
PubMed
Van Mil, J.W.F. and Schulz, M.:
A review of Pharmaceutical Care in Community Pharmacy in Europe.
Harvard Health Policy Review. 2006; 7 (1): 155–168.
Full
text
2005
Berger, K, Eickhoff, C. and Schulz, M.:
Counselling quality in community pharmacies:
Implementation of the pseudo customer methodology in Germany.
J. Clin. Pharm. Ther. 2005; 30 (1): 45–57.
PubMed
Mangiapane, S., Schulz, M., Mühlig, S., Ihle, P., Schubert, I. and Waldmann, H.-C.:
COMMUNITY PHARMACY-BASED PHARMACEUTICAL CARE FOR ASTHMA PATIENTS.
Ann. Pharmacother. 2005; 39 (11): 1817–1822.
PubMed
2004
Van Mil, J.W.F., Schulz, M. and Tromp, Th.F.J.:
PHARMACEUTICAL CARE, EUROPEAN DEVELOPMENTS IN CONCEPTS, IMPLEMENTATION, TEACHING, AND RESEARCH: A REVIEW.
Pharm. World Sci. 2004; 26 (6): 303–311.
PubMed
2003
Hauner, H., Maxion-Bergemann, S., Müller, E., Schulz, M., Huppertz, E. and Bergemann, R.:
DMP DIABETES MELLITUS: SIMULATION DER BEHANDLUNGSERGEBNISSE VERSCHIEDENER LEITLINIEN. Ein neues Diabetes
mellitus Modell (DMM).
[Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model
(DMM)].
Dtsch. Med. Wochenschr. 2003; 128 (21): 1167–1172.
PubMed
Schulz, M. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 800 DRUGS AND OTHER XENOBIOTICS.
Pharmazie. 2003; 58
(7): 447–474.
PubMed
2002
Azodi, K., Himstedt, S., Hinrichs, A., Krüger, M., Schrader, S. and Schulz, M.:
TESTING OF THE READABILITY OF PACKAGE LEAFLETS AS AN INITIAL STEP UNDER THE PHARMACEUTICAL CARE INITIATIVE TOWARDS INCREASING THE SAFETY OF MEDICINAL PRODUTCS.
Pharm. Ind. 2002; 64 (11): 1119–1125.
2001
Schulz, M., Schmoldt, A., Donn, F. and Becker, H.:
LACK OF METHEMOGLOBINEMIA WITH FLUTAMIDE.
Ann. Pharmacother. 2001; 35 (1): 21–25.
PubMed
Brockmeyer, R., Steindl, L., Behrens, I., Gnekow, S., Verheyen, F. and Schulz, M.:
Testing of the readability of package inserts at a community pharmacy.
Pharm. Ind. 2001; 63 (2): 114–119.
Online
Schulz, M., Verheyen, F., Mühlig, S., Müller, J.M., Mühlbauer, K., Knop-Schneickert, E., Petermann, F. and Bergmann, K.-C.:
PHARMACEUTICAL CARE SERVICES FOR ASTHMA PATIENTS: A CONTROLLED INTERVENTION STUDY.
J. Clin. Pharmacol. 2001; 41 (6): 668–676.
PubMed
Reports in, among
others: Pharm. J. 2001; 267 (14 July): 43 and FIP News 2001; 2 (9): 2.
2000
Stein, S., Schmoldt, A. and Schulz, M.:
FATAL INTOXICATION WITH MELPERONE.
Forensic Sci. Int. 2000; 113 (1-3):
409–413.
PubMed
Seibt, K., Schulz, M. and Hensel, F.J.:
MEINUNGEN UND EINSTELLUNGEN ZUM THEMA IMPFEN BEI NIEDERGELASSENEN ÄRZTEN, OFFIZINAPOTHEKERN UND IHREM PERSONAL SOWIE AKTUELLER IMPFSTATUS DIESER GRUPPEN
[Opinions and attitudes on the topic of vaccination of established physicians, pharmacists and their personnel and current vaccination status of these groups].
Gesundheitswesen 2000; 62 (7): 376–382.
PubMed
1999
Iwersen-Bergmann, S., Schmoldt, A., Püschel, K. and Schulz, M.:
VERGIFTUNGS- UND TODESFÄLLE DURCH SUBSTITUTIONSMITTEL IM UMFELD VON SUBSTITUIERTEN DROGENKONSUMENTEN
[Fatal and non-fatal poisonings with substitute drugs in the environment of substituted addicts].
Rechtsmedizin 1999; 9 (3): 90–93.
Abstract
Abstract
(German)
1997
Schulz, M.
and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 500 DRUGS.
Pharmazie 1997; 52 (12):
895–911.
PubMed
1996
Scholz, J., Steinfath, M. and Schulz, M.:
CLINICAL PHARMACOKINETICS OF ALFENTANIL, FENTANYL, AND SUFENTANIL: AN UPDATE.
Clin. Pharmacokinet.
1996; 31 (4): 275–292.
PubMed
1995
Scholz, J., Schulz, M., Steinfath, M., Höver, S. and Bause, H.:
FLUCONAZOLE IS REMOVED BY CONTINUOUS VENOVENOUS HEMOFILTRATION IN A
LIVER TRANSPLANT PATIENT.
J. Mol. Med. 1995; 73 (3): 145–147.
PubMed
Schmoldt, A., Sagowski, C., Iwersen, S. and Schulz, M.:
HEMMUNG DER ADH-AKTIVITÄT DES MAGENS DURCH H2-REZEPTORENBLOCKER
[Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists].
Rechtsmedizin 1995; 5: 73–77.
Fox, J.M., unter Mitarbeit von Menges, K., Coper, H., Doenicke, A., Ferner, U.J., Gaertner, H.J., Hoffmeister, F., Janke, W., Janzen, R.W.C., Kanowski, S., Kreiskott, H., Müller-Oerlinghausen,
B., Netter, P., Oelschläger, H., Poser, W., Radke, J., Rüther, E. and Schulz, M.:
KOMBINATIONSARZNEIMITTEL AUS PARACETAMOL PLUS ACETYLSALICYLSÄURE: NUTZEN UND RISIKEN
[Fixed-dosed combinations of paracetamol(acetaminophen) and aspirin: benefits and risks].
Schmerz 1995; 9: 273–285.
1994
Schulz, M. and Schmoldt, A.:
SUCCESSFUL PHYSOSTIGMINE TREATMENT OF ACUTE DOTHIEPIN INTOXICATION.
Pharmazie 1994; 49 (8):
614.
PubMed
Scholz, J., Bause, H., Schulz, M., Klotz, U., Krishna, D.R., Pohl, S. and Schulte am Esch,
J.:
PHARMACOKINETICS AND EFFECTS ON INTRACRANIAL PRESSURE OF SUFENTANIL IN HEAD TRAUMA PATIENTS.
Br. J.
Clin. Pharmacol. 1994; 38 (4): 369–372.
PubMed
Schulz, M. and Schmoldt, A.:
ZUSAMMENSTELLUNG THERAPEUTISCHER UND TOXISCHER PLASMAKONZENTRATIONSBEREICHE VON ARZNEISTOFFEN
[Therapeutic and toxic plasma concentrations: a compilation].
Anaesthesist 1994; 43 (12):
835–844.
PubMed
1993
Schulz, M. and Schmoldt, A.:
NON-INTERACTION OF RANITIDINE WITH HYDROXYLATION OF DICLOFENAC IN RAT AND HUMAN LIVER MICROSOMES.
Pharmazie 1993; 48 (8): 625–626.
PubMed
1992
Schulz, M. and Schmoldt, A.:
KONZENTRATIONEN VON CEFOTIAM IM KOLONGEWEBE UND PLASMA NACH APPLIKATION ZUR PERIOPERATIVEN ANTIBIOTIKA-PROPHYLAXE
[Concentrations of cefotiam in colon tissue and plasma after application for perioperative antibiotic prophylaxis].
Zeitschr.
Antimikrobiol. Antineoplast. Chemother. 1992; 10: 33–37.
1991
Schulz, M., Wischhusen, F. and Schmoldt, A.:
THERAPEUTISCHE UND TOXISCHE PLASMAKONZENTRATIONEN SOWIE ELIMINATIONSHALBWERTSZEITEN GEBRÄUCHLICHER ARZNEISTOFFE.
Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1991; 26 (1): 37–43.
PubMed
Schulz, M. and Schmoldt, A.: Pharm. Ztg.
Wiss. 1991; 136 (4): 87–94 [extended reprint].
1989
Donn, F.,
Bruns, T., von Meyerinck, L., Schulz, M., Becker, W.-M., Becker, H. and Klosterhalfen, H.:
MONOCLONAL ANTIBODY THAT DEFINES THE PROSTATE SPECIFIC ANTIGEN.
Prostate 1989; 14 (3): 237–249.
PubMed
Schulz, M.,
Meyer, W., Schmitz, W., Scholz, J. and Schmoldt, A.:
BETA-REZEPTORENBLOCKER: GRUNDLAGEN ZUR ARZNEIMITTELAUSWAHL FÜR EINE RATIONALE THERAPIE
[Beta receptor blockers. Principles for drug selection for rational therapy].
Med. Monatsschr. Pharm.
1989; 12 (8): 237–244.
PubMed
Reprint in: Arzneimittelther. 1989; 7 (6): 169–176.
Schulz, M. and
Schmoldt, A.:
DETERMINATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN HUMAN PLASMA BY HIGH-PERFORMANCE
LIQUID CHROMATOGRAPHY.
Pharm. Ztg. Wiss. 1989; 134 (2): 41–44.
1988
Frese, J.H., Rohland, L., Schulz, M. and Schmoldt, A.:
INTOXIKATION MIT GALLOPAMIL. Verlauf und Therapie
[Gallopamil poisoning. Its course and therapy].
Dtsch. Med. Wochenschr.
1988; 113 (19): 770–772.
PubMed
Schulz, M.:
INTERAKTIONEN AUSGEWÄHLTER HISTAMIN H2-REZEPTORANTAGONISTEN MIT DEM
CYTOCHROM P-450-SYSTEM UND MÖGLICHE AUSWIRKUNGEN AUF DIE PHARMAKO-
KINETIK NICHTSTEROIDALER ANTIRHEUMATIKA.
[Interactions of selected histamine H2-receptor antagonists with the
cytochrome P-450 system and potential effects on the pharmacokinetics of non-steroidal antiinflammatory drugs].
PhD thesis (Dr. rer. nat.). University Hamburg. August 1988.
Schulz, M.,
Schmoldt, A., Donn, F. and Becker, H.:
THE PHARMACOKINETICS OF FLUTAMIDE AND ITS MAJOR METABOLITES AFTER A SINGLE ORAL DOSE AND DURING CHRONIC TREATMENT.
Eur. J. Clin. Pharmacol. 1988; 34 (6): 633–636.
PubMed
Schulz, M. and Schmoldt, A.:
ON THE SULPHOXIDATION OF CIMETIDINE AND ETINTIDINE BY RAT AND HUMAN LIVER MICROSOMES.
Xenobiotica 1988; 18
(8): 983–989.
PubMed
1987
Schulz, M. and Schmoldt, A.:
INTERACTIONS OF THE HISTAMINE H2-RECEPTOR ANTAGONIST ETINTIDINE WITH RAT LIVER CYTOCHROME P-450:
A COMPARISON WITH CIMETIDINE.
Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 336 (4): 453–458.
PubMed